Biomind Labs Overview
- Year Founded
-
2020
- Status
-
Public
- Employees
-
3
- Stock Symbol
-
BMND
- Investments
-
1
- Share Price
-
$0.21
- (As of Friday Closing)
Biomind Labs General Information
Description
Biomind Labs Inc is a biotech research and development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. The firm is developing pharmaceutical solutions and combined formulations of the main natural psychedelic molecules with the objective of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.
Contact Information
Website
www.biomindlabs.comCorporate Office
- 217 Queen Street West
- Suite 401
- Toronto, Ontario
- Canada
Corporate Office
- 217 Queen Street West
- Suite 401
- Toronto, Ontario
- Canada
Biomind Labs Stock Performance
As of 13-Nov-2026, Biomind Labs’s stock price is $0.21. Its current market cap is $16.3M with 77.6M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.21 | $0.21 | $16.3M | 77.6M | 1.93K | -$0.02 |
Biomind Labs Financials Summary
As of 30-Jun-2026, Biomind Labs has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 4,578 | 10,861 | 23,241 | 8,342 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (1,383) | (779) | (219) | (1,016) |
| Net Income | (1,454) | (850) | (260) | (1,192) |
| Total Assets | 0 | 0 | 41 | 74 |
| Total Debt | 829 | 728 | 671 | 739 |
Biomind Labs Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Biomind Labs Patents
Biomind Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230094051-A1 | Dimethyltriptamine-based nasal spray for the personalised treatment of neurological and psychiatric disorders | Inactive | 27-Dec-2021 | ||
| US-20240408063-A1 | Encapsulated microparticles and nanoparticles of dimethyltriptamines | Pending | 27-Dec-2021 | ||
| US-20230097076-A1 | Pharmaceutical formulation containing a psychedelic substance obtained by selective laser sintering (sls) 3d printing | Inactive | 27-Dec-2021 | ||
| EP-4159192-A1 | Dimethyltriptamine-based nasal spray for the personalised treatment of neurological and psychiatric disorders | Inactive | 30-Sep-2021 | ||
| EP-4159201-A1 | Encapsulated microparticles and nanoparticles of dimethyltriptamines | Pending | 30-Sep-2021 | A61K31/4045 |
Biomind Labs Signals
Biomind Labs Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Biomind Labs Acquisitions (1)
Biomind Labs’s most recent deal was a Merger/Acquisition with Crosswinds Holdings. The deal was made on 23-Jul-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Crosswinds Holdings | 23-Jul-2021 | Merger/Acquisition | Private Equity |
Biomind Labs ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Banks
Industry
Rank
Percentile
Development Banks
Subindustry
Rank
Percentile
Biomind Labs FAQs
-
When was Biomind Labs founded?
Biomind Labs was founded in 2020.
-
Where is Biomind Labs headquartered?
Biomind Labs is headquartered in Toronto, Canada.
-
What is the size of Biomind Labs?
Biomind Labs has 3 total employees.
-
What industry is Biomind Labs in?
Biomind Labs’s primary industry is Drug Discovery.
-
Is Biomind Labs a private or public company?
Biomind Labs is a Public company.
-
What is Biomind Labs’s stock symbol?
The ticker symbol for Biomind Labs is BMND.
-
What is the current stock price of Biomind Labs?
As of 13-Nov-2026 the stock price of Biomind Labs is $0.21.
-
What is the current market cap of Biomind Labs?
The current market capitalization of Biomind Labs is $16.3M.
-
What is Biomind Labs’s annual earnings per share (EPS)?
Biomind Labs’s EPS for 12 months was -$0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process